15 research outputs found
Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill
Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review
CARDIAC HYDATID DISEASE: INCLUDING A REPORT ON THE SUCCESSFUL REMOVAL OF A COMPLICATED HYDATID CYST, OCCUPYING THE FULL THICKNESS OF THE LEFT VENTRICULAR MYOCARDIUM, UTILIZING CARDIO-PULMONARY BY-PASS
Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemic [Registo internacional da Iniciativa Stent-Save a Life sobre a prática de angioplastia coronária primária durante a pandemia de COVID-19]
Aim: To assess the impact of the COVID-19 pandemic on admissions of patients with acute coronary syndromes (ACS) and primary percutaneous coronary intervention (PPCI) in countries participating in the Stent-Save a Life (SSL) global initiative. Methods and Results: We conducted a multicenter observational survey to collect data on patient admissions for ACS, ST-elevation myocardial infarction (STEMI) and PPCI in participating SSL member countries through a period during the COVID-19 outbreak (March and April 2020) compared with the equivalent period in 2019. Of the 32 member countries of the SSL global initiative, 17 agreed to participate in the survey (three in Africa, five in Asia, six in Europe and three in Latin America). Overall reductions of 27.5% and 20.0% were observed in admissions for ACS and STEMI, respectively. The decrease in PPCI was 26.7%. This trend was observed in all except two countries. In these two, the pandemic peaked later than in the other countries. Conclusions: This survey shows that the COVID-19 outbreak was associated with a significant reduction in hospital admissions for ACS and STEMI as well as a reduction in PPCI, which can be explained by both patient- and system-related factors. © 202